Atrium Therapeutics
Atrium is seeking an experienced Associate Director to lead its Translational Medicine function, overseeing clinical biomarker strategy and bioinformatics across cardiomyopathy programs. The role will define biomarker strategies, manage assay development and validation, and guide bioinformatics support for R&D, while mentoring a growing team of scientists.
Our vision is to pioneer precision RNA medicines for the heart and profoundly improve the lives of people impacted by cardiac diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Atrium Therapeutics.
Sr. Scientist, Translational Medicine
RayzeBio
Vice President, Translational Medicine
Annexon Biosciences
Head of Translational & Precision Medicine
USAJOBS
Associate Director, Translational Research Hematology R&D
AstraZeneca
Director, Cell Therapy Translational Medicine & Bioanalysis
AstraZeneca
Associate Director, Bioanalytical Sciences & Biomarkers
Arbor Biotechnologies